Olanzapine long-acting injectable (LAI) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation, for a ...

Teva files an NDA seeking FDA approval for its once-monthly olanzapine LAI for the treatment of adults with schizophrenia.

In April 2025, CMG Pharmaceutical, a subsidiary of CHA Biotech, secured FDA approval for Mezofy (formerly Depipzo), an oral ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares began Tuesday sharply higher. The company today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug ...

Newron Pharmaceuticals SpA ( ($CH:NWRN) ) just unveiled an announcement. Newron Pharmaceuticals has announced the US launch of its global Phase ...

CINCINNATI, Ohio. (Ivanhoe Newswire) --- Schizophrenia - the statistics are terrifying; more than 3.7 million people are living with it right now in the United States. If left untreated it can be ...

Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...

Schizophrenia has long been framed as a disorder of broken thoughts and fractured perception, but a new line of research ...

Panelists discuss how CT-155, a 16-week interactive digital application, met its primary end point in clinical trials by ...

Researchers discovered that some variants of the gene known as GRIN2A can cause certain conditions all on their own.

People living with schizophrenia continue to battle not just their symptoms, delayed diagnoses and access to quality ...